Product Information

CICLOPIROX 0.77% CREAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1628 per GM under NDC 45802013811. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Mar 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Ciclopirox olamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CICLOPIROX 0.77% CREAM

Ciclopirox olamine
$0.1628per GM
High Outlier

Strength

7.7 mg/g

NDC

45802013811

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

CICLOPIROX OLAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA077364

FDA Approved

3/3/2006

TE Code

AB

On Market Since

7/19/2006

Pharmacological Classes

Decreased DNA Replication
Decreased Protein Synthesis
Decreased RNA Replication
Protein Synthesis Inhibitors

Price Statistics

The NADAC for CICLOPIROX 0.77% CREAM has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 50.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1628 per GM
All-time high$0.5583 (Aug 13, 2014)
All-time low$0.1620 (Nov 20, 2024)
52-week high$0.1992
52-week low$0.1628
Median price$0.2193
Average price$0.2551
Largest weekly change+64.2% (Feb 18, 2015)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-3.3%

1M

-3.5%

3M

-5.8%

6M

-11.3%

1Y

-5.6%

3Y

-21.1%

5Y

-21.1%

All

-50.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 41%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CICLOPIROX 0.77% CREAM?

The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 0.77% CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1628 per GM (NDC 45802013811), effective Nov 18, 2026.

How has the price of CICLOPIROX 0.77% CREAM changed over time?

Over the history we have for it, the NADAC for CICLOPIROX 0.77% CREAM has declined 50.3%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CICLOPIROX 0.77% CREAM?

Since Nov 28, 2013, the NADAC for CICLOPIROX 0.77% CREAM has ranged from a low of $0.1620 (Nov 20, 2024) to a high of $0.5583 (Aug 13, 2014), with a median of $0.2193 per GM.

Are there cheaper alternatives to CICLOPIROX 0.77% CREAM?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CICLOPIROX 0.77% CREAM, is $0.0963 per GM — about 41% below CICLOPIROX 0.77% CREAM.

Who manufactures CICLOPIROX 0.77% CREAM?

CICLOPIROX 0.77% CREAM (NDC 45802013811) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.